iCell Gene Therapeutics
PrivateLast Round
Grant
Oct 8, 2020
Total Funding Raised
$3.1M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
iCell Gene Therapeutics is a biotechnology company that develops chimeric antigen receptor (CAR) immunotherapies for the treatment of autoimmune diseases and cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
iCell Gene Therapeutics Comparables
Compare iCell Gene Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Luminary Therapeutics, Inc. | 82% | |
| AstraZeneca | 81% | |
| Lyell Immunopharma | 77% | |
iCell Gene Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 8, 2020 |
Key People
Founding team and executive leadership
iCell Gene Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Long Island High Technology Incubator | Accelerator |
| Food and Drug Administration | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 2, 2026
Grew 27% QoQ from 11 to 14 employees.
- May 19, 2026
Monthly visitors grew 33% MoM, reaching 961.
iCell Gene Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about iCell Gene Therapeutics's valuation, stock price, and market status.